Solvay Gets Good News on Luvox CR
Solvay Pharmaceuticals has received a $20 million milestone payment with the FDA’s approval of Luvox CR, a treatment for social anxiety and obsessive compulsive disorder.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.